Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Nike, Tesla, Humana, and More
These Stocks Are Moving the Most Today: Tesla, Levi Strauss, Humana, Hims & Hers, Nvidia, Stellantis, and More
Tesla extends losses following the release of third-quarter deliveries, and Levi Strauss tumbles after cutting its fiscal-year revenue outlook.
Top Stock Movers Now: Nike, Tesla, Humana, and More
Key Takeaways Major U.S. indexes were little changed at midday Wednesday, as investors watch developments in the Middle East and the U.S. port strike. Nike shares fell Wednesday, a day after the company declined to offer a full-year outlook alongside its fiscal first-quarter results.
Midday stock movers: Nike, Tesla, Humana
Related: Analyst resets Tesla stock price target ahead of Q3 deliveries. Tesla is scheduled to post its Q3 financial results after the market close Oct. 23. Tesla stock is down 0.
These Stocks Are Moving the Most Today: Humana, Nike, Tesla, Conagra, Joby Aviation, Caesars, and More
Humana stock sinks on Medicare Advantage troubles, Nike withdraws fiscal 2025 guidance as it changes chief executives, and Tesla reports third-quarter deliveries that came in slightly higher than estimates.
Humana, Medicare
Medicare Advantage giant Humana reels after ratings cut
The insurer’s stock sank to its lowest level in more than a decade after the federal government lowered the rating for one of its most popular plans.
Quality ratings hit to key Medicare plan shakes Humana stock
Shares of Humana have tumbled after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus payments the company receives.
Humana’s Ratings Debacle Exacerbates Tough Year for New CEO
Humana Inc. shares plummeted the most in 15 years after the insurer suffered a drop in Medicare Advantage quality ratings, posing a drastic threat to revenue.Most Read from BloombergA 7,000-Year-Old C
17h
Humana cut to underperform by BofA on margin recovery delay
Humana (HUM) was downgraded to underperform by BofA, which cited an ongoing delay in margin recovery amid news the company ...
6h
Humana’s Star Rating Decline Prompts Hold Rating Amid Financial Uncertainty
Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...
17h
Humana plunges as Medicare star rating cut threatens revenue
Medicare Advantage quality ratings for the company dropped, meaning a big drop in revenue from bonus payments.
23h
Humana: 2026 Earnings Likely To Be Crushed
The recent developments have cratered Humana stock price, and it is now trading under our earlier targets. Read why we remain ...
6h
Buy Rating Affirmed: Humana’s Proactive Strategies to Mitigate Earnings Headwinds
Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Baxter from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Medicare
Tesla
S&P 500 Index
Levi Strauss
Nike
Feedback